Upcoming Webinar :Register now for 'ULIP as an investment during economic recovery' powered by Bajaj Allianz

Indian Rupee Settles 7 Paise Higher At 75.58 Against US Dollar

Forex traders said weak domestic equities, foreign fund outflows and rising COVID-19 cases weighed on investor sentiments. However, weak American dollar supported the local unit and restricted the decline.

Jun 29, 2020 / 02:30 PM IST

The rupee settled 7 paise higher at 75.58 (provisional) against the US dollar on Monday supported by weak American currency and easing crude prices even as the equity market was trading in the negative territory.

Forex traders said weak domestic equities, foreign fund outflows and rising COVID-19 cases weighed on investor sentiments. However, weak American dollar supported the local unit and restricted the decline.

The rupee opened on a flat note at the interbank forex market at 75.64 against the US dollar, then gained ground and finally settled for the day at 75.58 against the US dollar, up 7 paise over its last close.

It had settled at 75.65 against the US dollar on Friday.

During the four-hour trading session the domestic unit touched an intra-day high of 75.52 and a low of 75.64 against the US dollar.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Meanwhile, the number of cases around the world linked to the disease has crossed 1.01 crore and the death toll has topped 5.01 lakh.

In India, the death toll due to COVID-19 rose to 16,475 and the number of infections rose to 5,48,318, according to the health ministry.

On the equities front, the 30-share BSE benchmark Sensex was quoting 345.82 points lower at 34,825.45 and the broader Nifty fell 109.90 points to 10,273.10.

Foreign institutional investors were net sellers in the capital market, as they sold equity shares worth Rs 753.18 crore on Friday, according to provisional exchange data.

Brent crude futures, the global oil benchmark, fell 2.15 per cent to USD 40.14 per barrel.

The dollar index, which gauges the greenback's strength against a basket of six currencies, fell by 0.09 per cent to 97.34.
PTI
first published: Jun 29, 2020 02:30 pm

stay updated

Get Daily News on your Browser
Sections